4.7 Article

Progranulin promotes bone fracture healing via TNFR pathways in mice with type 2 diabetes mellitus

期刊

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
卷 1490, 期 1, 页码 77-89

出版社

WILEY
DOI: 10.1111/nyas.14568

关键词

impaired fracture healing; progranulin; TNF‐ α tumor necrosis factor receptors; type 2 diabetes

资金

  1. National Institutes of Health [R01AR076900, R01AR062207, R01AR061484, 1R01NS103931]
  2. U.S. Department of Defense [W81XWH-16-1-0482]

向作者/读者索取更多资源

This study found that PGRN expression was increased in bone fracture healing in T2DM. In vivo experiments showed that recombinant PGRN effectively promoted fracture healing and exhibited anti-inflammatory activity in the regeneration process. Exogenous PGRN may be an alternative strategy to support bone regeneration in T2DM patients.
Type 2 diabetes mellitus (T2DM) significantly increases bone fragility and fracture risk. Progranulin (PGRN) promotes bone fracture healing in both physiological and type 1 diabetic conditions. The present study aimed to investigate the role of PGRN in T2DM bone fracture healing. MKR mice (with an FVB/N genetic background) were used as the T2DM model. Drill-hole and Bonnarens and Einhorn models were used to investigate the role of PGRN in T2DM fracture healing in vivo. Primary bone marrow cells were isolated for molecular and signaling studies, and reverse transcription-polymerase chain reaction, immunohistochemical staining, and western blotting were performed to assess PGRN effects in vitro. PGRN mRNA and protein expression were upregulated in the T2DM model. Local administration of recombinant PGRN effectively promoted T2DM bone fracture healing in vivo. Additionally, PGRN could induce anabolic metabolism during endochondral ossification through the TNFR2-Akt and Erk1/2 pathways. Furthermore, PGRN showed anti-inflammatory activity in the T2DM bone regeneration process. These findings suggest that local administration of exogenous PGRN may be an alternative strategy to support bone regeneration in patients with T2DM. Additionally, PGRN might hold therapeutic potential for other TNFR-related metabolic disorders.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据